The serpin superfamily and their role in the regulation and dysfunction of serine protease activity in COPD and other chronic lung diseases

GA Kelly-Robinson, JA Reihill, FT Lundy… - International journal of …, 2021 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a debilitating heterogeneous disease
characterised by unregulated proteolytic destruction of lung tissue mediated via a protease …

Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis

AV Gaikwad, MS Eapen, KD McAlinden… - Expert review of …, 2020 - Taylor & Francis
Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible
fibrotic disease associated with respiratory failure. The disease remains idiopathic, but …

Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis

TM Dempsey, LR Sangaralingham, X Yao… - American journal of …, 2019 - atsjournals.org
Rationale: Since their approval, there has been no real-world or randomized trial evidence
evaluating the effect of the antifibrotic medications pirfenidone and nintedanib on clinically …

Vascular dysfunction in aged mice contributes to persistent lung fibrosis

N Caporarello, JA Meridew, A Aravamudhan… - Aging cell, 2020 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a progressive disease thought to result from impaired
lung repair following injury and is strongly associated with aging. While vascular alterations …

Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction

Y Xie, L Liu - Journal of translational medicine, 2022 - Springer
Sufficient epidemiological investigations demonstrate that there is a close correlation
between obesity and vascular dysfunction. Nevertheless, specific mechanisms underlying …

[HTML][HTML] Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis

LA Murray, DM Habiel, M Hohmann, A Camelo… - JCI insight, 2017 - ncbi.nlm.nih.gov
The chronic progressive decline in lung function observed in idiopathic pulmonary fibrosis
(IPF) appears to result from persistent nonresolving injury to the epithelium, impaired …

Expression of WNT5A in idiopathic pulmonary fibrosis and its control by TGF-β and WNT7B in human lung fibroblasts

DR Newman, WS Sills, K Hanrahan… - … of Histochemistry & …, 2016 - journals.sagepub.com
The wingless (Wnt) family of signaling ligands contributes significantly to lung development
and is highly expressed in patients with usual interstitial pneumonia (UIP). We sought to …

Antioxidant activity mediates pirfenidone antifibrotic effects in human pulmonary vascular smooth muscle cells exposed to sera of idiopathic pulmonary fibrosis …

AG Fois, AM Posadino, R Giordo… - Oxidative medicine …, 2018 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by an
exacerbated fibrotic response. Although molecular and cellular determinants involved in the …

Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro

S Zeinali, CA Bichsel, N Hobi, M Funke, TM Marti… - Angiogenesis, 2018 - Springer
Idiopathic pulmonary fibrosis is characterized by a progressive scarring and stiffening of the
peripheral lung tissue that decreases lung function. Over the course of the disease, the lung …

[HTML][HTML] Cell-based therapy for idiopathic pulmonary fibrosis

Q Lu, AHK El-Hashash - Stem cell investigation, 2019 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is an example of interstitial lung diseases that is
characterized by chronic, progressive, and fibrotic lung injuries. During lung fibrosis, normal …